Abstract
A proportion of children and adults with moderate to severe atopic eczema are not adequately controlled with emollients and topical steroids, resulting in significant morbidity and disability. Studies indicate a significant placebo response, so randomized controlled trials of new treatments are vital. This article reviews the evidence for phototherapy and systemic treatments in atopic eczema.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adjuvants, Immunologic / therapeutic use
-
Adolescent
-
Adult
-
Child
-
Child, Preschool
-
Cyclosporine / therapeutic use
-
Dermatitis, Atopic / therapy*
-
Dermatologic Agents / therapeutic use
-
Drugs, Chinese Herbal / therapeutic use
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Infant
-
Infant, Newborn
-
Interferon-gamma / toxicity
-
Phototherapy / methods*
-
Steroids / therapeutic use
-
Thymopentin / therapeutic use
Substances
-
Adjuvants, Immunologic
-
Dermatologic Agents
-
Drugs, Chinese Herbal
-
Immunosuppressive Agents
-
Steroids
-
Interferon-gamma
-
Cyclosporine
-
Thymopentin